Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03430154
Other study ID # HAEM-4414
Secondary ID U1111-1199-8271
Status Completed
Phase
First received
Last updated
Start date December 1, 2017
Est. completion date April 29, 2018

Study information

Verified date September 2018
Source Novo Nordisk A/S
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

An online web-based cross-sectional survey in which participants will complete a distinct questionnaire for patients with hemophilia and obesity (PwHO) and/or their carers/spouses/partners, or a distinct questionnaire for healthcare professionals. Each questionnaire consists of more than 100 items including pre-coded (multiple choice) closed-ended questions, yes/no questions and rating scales. It is estimated that this one-off survey will take approximately 45-60 minutes to complete.

As a cross-sectional study, there will be no treatment of patients.


Recruitment information / eligibility

Status Completed
Enrollment 317
Est. completion date April 29, 2018
Est. primary completion date April 29, 2018
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Meeting one of the following criteria: a) Adults (any gender) aged equal to or more than 18 years with hemophilia (any severity, with or without inhibitors) self-identified with obesity or overweight, - OR - Caregivers of children (any gender) currently aged less than18 years with hemophilia (any severity, with or without inhibitors) caregiver-identified with obesity or overweight, - OR - Spouses or partners of adults (any gender) aged equal to or more than 18 years with hemophilia (any severity, with or without inhibitors) self-identified with obesity or overweight - OR - Healthcare professional (pediatric or adult hematologist, nurse, nurse practitioner, physician assistant, physical therapist, social worker) actively working in a federally designated hemophilia-treatment center for at least 3 years and with experience managing patients with hemophilia and obesity or overweight.

- Participants must have access to the internet, either at home or at a location convenient to them

- Provision of informed consent before the start of any survey-related activities.

Exclusion Criteria:

- Inability to understand and comply with written instructions in English

- Previous completion of this study with receipt of compensation

- Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No treatment given
No treatment given

Locations

Country Name City State
United States Novo Nordisk Investigational Site Plainsboro New Jersey

Sponsors (1)

Lead Sponsor Collaborator
Novo Nordisk A/S

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prevalence of obesity awareness and perceptions Data is collected via online questionnaires Start of interviews day 1 until end of data collection day 90
Primary Prevalence of attitudes on obesity Data is collected via online questionnaires Start of interviews day 1 until end of data collection day 90
Primary Prevalence of weight loss support structure Data is collected via online questionnaires Start of interviews day 1 until end of data collection day 90
Primary Prevalence of interactions between patients and HCPs around obesity/overweight Data is collected via online questionnaires Start of interviews day 1 until end of data collection day 90
Primary Prevalence of awareness about weight loss solutions Data is collected via online questionnaires Start of interviews day 1 until end of data collection day 90
Primary Characteristics of obesity awareness and perceptions Data is collected via online questionnaires Start of interviews day 1 until end of data collection day 90
Primary Characteristics of attitudes on obesity Data is collected via online questionnaires Start of interviews day 1 until end of data collection day 90
Primary Characteristics of weight loss support structure Data is collected via online questionnaires Start of interviews day 1 until end of data collection day 90
Primary Characteristics of interactions between patients and HCPs around obesity/overweight Data is collected via online questionnaires Start of interviews day 1 until end of data collection day 90
Primary Characteristics of awareness about weight loss solutions Data is collected via online questionnaires Start of interviews day 1 until end of data collection day 90